Results 261 to 270 of about 157,199 (404)

Immunophenotyping in Vernal Keratoconjunctivitis: Schirmer Test for Therapy Response Prediction

Allergy, EarlyView.
Maria Teresa Bilotta, Paola Vacca, Mariacristina Esposito, Luca Buzzonetti, Giuseppe Bianco, Alessandro Giovanni Fiocchi, Lorenzo Moretta, Massimiliano Raponi, Maria Cristina Artesani, Nicola Tumino   +9 more
wiley   +1 more source

Diagnostic testing and treatment in Japanese patients with a diagnosis code for chronic inflammatory demyelinating polyradiculoneuropathy: A claims database analysis

Clinical and Experimental Neuroimmunology, Volume 16, Issue 2, Page 98-107, May 2025.
Abstract Objectives Reports of real‐world data concerning chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are limited in Japan. This study aimed to investigate the diagnostic testing and treatment performed in patients diagnosed with CIDP in Japan. Methods Using a Japanese commercial medical information database, we analyzed diagnostic
Motoi Kuwahara, Susumu Kusunoki, Ataru Igarashi, Satoshi Akiyama, Taku Fukushima, Mamoru Doi   +5 more
wiley   +1 more source

REVERSAL OF EARLY ACUTE REJECTION WITH INCREASED DOSES OF TACROLIMUS IN LIVER TRANSPLANTATION

, 1998
Olivier Boillot, Jean–Paul Viale, P Gratadour, Pierre Méeus, Pierre Souraty, Y Le Derf, Isabelle Méchet, Jean‐Yves Scoazec, Francoise Berger, P Paliard   +9 more
openalex   +1 more source

Lymphocyte‐sensitivity to glucocorticoid correlates with the sensitivity to cyclosporin A and tacrolimus in chronic renal failure patients [PDF]

, 1999
Horigome, Hirano, Oka, T. Takeuchi, Sakurai, Kozaki, Matsuno, Nagao, Kozaki   +8 more
openalex   +1 more source

Possible Tacrolimus-associated seronegative Autoimmune Encephalitis presenting with subacute cognitive impairment and disorientation - case report. [PDF]

Front Med (Lausanne)
Hölzl K, Albasini F.
europepmc   +1 more source

Tacrolimus [PDF]

Reactions Weekly, 2021
openaire   +1 more source

Real‐world safety and treatment patterns of subcutaneous IgPro20 for chronic inflammatory demyelinating polyneuropathy: Post‐marketing surveillance in Japan

Clinical and Experimental Neuroimmunology, Volume 16, Issue 2, Page 108-117, May 2025.
Abstract Objectives IgPro20, a subcutaneous immunoglobulin replacement therapy, is approved in Japan for chronic inflammatory demyelinating polyneuropathy (CIDP). This post‐marketing surveillance study characterized real‐world treatment patterns and safety profile of injection site reactions associated with IgPro20 treatment in Japanese patients with ...
Naoki Terasaka, Takanori Mizushima, Yuki Niwa, Tetsushi Akasaki, Hideo Usui   +4 more
wiley   +1 more source

Optimizing Tacrolimus Dosing During Hospitalization After Kidney Transplantation: A Comparative Model Analysis. [PDF]

Ann Transplant
Mok S, Park SC, Yun SS, Park YJ, Sin D, Hyun JK.   +5 more
europepmc   +1 more source

Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta‐Analysis

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To identify evidence on the use of topical CsA for ocular surface diseases (OSD). Methods A literature search was conducted following the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) through June 2023 via Cochrane Central Registries, Clinical Trials Registry, Grey literature and citation searching ...
Ngozi C. Chidi‐Egboka, Leo Fan, Maria Qureshi, Chameen Samarawickrama, Fiona Stapleton, Tanya Trinh, Maria Markoulli, Elsie Chan, Jern Yee Chen, Jason Holland, Stephanie L. Watson   +10 more
wiley   +1 more source

Evaluating the Efficacy of Topical Tacrolimus Alone and in Combination with Prednisolone for Treating Subepithelial Infiltrates in Epidemic Keratoconjunctivitis. [PDF]

Biomedicines
Karaca EE, Çelik G, İdacı Koç Ş, Evren Kemer Ö.   +3 more
europepmc   +1 more source